RxDoctor Payments Data

Gregory Randolph, MD

Otolaryngology · Boston, MANPI 1588655690

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 78.4% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $23,314, more than ten times the $1,390 reported in 2020. Among otolaryngology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$55,898in general payments, 2019–2025

Across 30 payments — averaging $1863.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$44K
  • Eisai Inc.$10K
  • Fluoptics SAS$2K
  • Covidien LP$27
$493,664in research payments, 2019–2025

Across 8 payments — averaging $61,708 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eisai Inc.$481K
  • Medtronic$13K

What the payments were for

  • Consulting fees$30,55855%
  • Speaking & faculty fees$21,60039%
  • Travel & lodging$3,1806%
  • Food & beverage$5611%

General payments by program year

20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic23$43,818
Eisai Inc.4$10,288
Fluoptics SAS2$1,766
Covidien LP1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,898 in reported general payments places this provider in the 95th percentile of 298 otolaryngology providers in Massachusetts.

See all otolaryngology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$66,995
Medicare patients
203
Services billed
401

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otolaryngology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →